follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Celsion gets $15 million in sale of preferred stock

By

Back to Top Comments Email Print

Latest News

advertisement

Biotech company Celsion Corp., in Lawrenceville, announced Friday that institutional investors have agreed to purchase $15 million of the company's securities in a direct offering.

Celsion agreed to sell 15,000 shares of its preferred stock — convertible into a total of approximately 12.1 million shares of common stock — and warrants potentially exercisable for up to approximately 6 million additional shares of its common stock. The estimated net proceeds to Celsion are expected to be approximately $13.8 million.

 

 

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top